Last deal

$2.5M

Amount

Debt Financing

Stage

01.03.2022

Date

8

all rounds

$24.8M

Total amount

General

About Company
NanoView Biosciences develops medical technology products for precision medicine research, translation, and delivery.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Nanoview, nanoView Diagnostics

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

The company's novel technology platform uniquely identifies and characterizes exosomes, enabling life science researchers to better understand their biological role and use them as biomarkers for improved disease diagnosis, treatment, and monitoring. Their high-throughput, cost-effective analysis solutions allow for the detection and multiparametric characterization of extracellular vesicles from complex samples like whole blood, serum, plasma, and urine, providing doctors with accurate detection and full characterization of exosomes and extracellular vesicles.
Contacts

Social url